LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”

Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...
BMJ Open

Aerobic dance during chemotherapy in patients with breast cancer with cognitive impairment (ADANC): protocol for an assessor-blinded randomised clinical trial

Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise ...
Scientific Research Publishing

Application of Cognitive Behavioral Therapy in Hospice Care of Cancer Patients ()

Cognitive Behavioral Therapy, Cancer, Hospice Care, Palliative Care, Anxiety, Quality of Life Share and Cite: Tang, L.L. and ...
The Lancet

The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...